Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age65-75
SponsorUniversity of Nottingham

About this trial

Sarcopenia describes the progressive decline of muscle mass and strength with advancing age and is associated with increased frailty and morbidity, however we do not currently have an effective treatment. Protein feeding and exercise is known to increase muscle mass, but aged muscle shows a lower response to these stimuli leading to muscle loss over time. We do know that ingesting leucine, a building block of protein, can overcome this reduced response to protein feeding and exercise leading to increased muscle mass in older people. However, we do not understand when the optimum time to ingest leucine is to maximise muscle mass after exercise in older people. In this study we will examine the effect of feeding leucine after exercise either with a meal or between meals.

Eligibility criteria

Qualifiers

Male, 65-75 years of age

BMI 18-28 kg/m2

Non smoker

Not performing regular resistance type exercise

Disqualifiers

A BMI <18 or >28 kg·m-2

Active cardiovascular disease: uncontrolled hypertension (BP > 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event

Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial)

Respiratory disease including pulmonary hypertension or chronic obstructive pulmonary disease (COPD)

Trial design

Treatments tested in this trial

  • Leucine

Treatment groups

10 Participants
are divided into 2 treatment groups

Sponsors and collaborators